FDA Approves First Migraine Prevention Drug!

Just last week, the FDA approved the first drug designed to prevent migraines! It’s been all people are talking about in the headache/migraine community, because it’s a pretty big deal!

Living with migraines is tougher than most people can imagine. What can be even tougher, is finding the right doctor, the right treatment and finding both without going broke.

Check out a few links that I found to be helpful in reading about this new FDA approved migraine prevention drug and how it can be accessed:

 

Monday Mantra: It’s Ok To Say No

It’s hard to do, but it’s definitely possible. Being a people pleaser is a great thing and a terrible thing, because it can be hard to do what is truly right for yourself. But guess what? You’re still an awesome person even if you say no every once in a while. 
Living with a chronic illness, I have to say no to a lot of things. It’s not a great feeling. So when I can, I usually say yes to all of the things I can say yes to. This could include plans, favors, etc. 

Sometimes I find myself saying yes even when I know I shouldn’t. Like when I say yes to going out even though my head is begging me to stay in. I hate disappointing my friends.

But we need to be able to listen to our bodies and not feel guilty when we have to say no. Do what you need to do for yourself to feel happy and healthy. 

Raise Your Hand If You’ve Ever Been Personally Victimized By Headaches

I’ve been living with two sure things my entire life. Two things that have never let me down and are always there for me each and every day. My love of writing and my chronic daily headaches. I’ve decided to put the two together to create an outlet for me when I’m feeling frustrated about my disorder and for others who might just be feeling the exact same way. It’s sadly comforting to know that other people out there are in the same pain that you are. We’re all looking for answers, magic cures, and support groups. While I can’t offer the first two, I might be able to offer the last.